Loading…
Beam Therapeutics Inc. is projected to rise to $36.21 by 2027, a +14% move from its current price of $31.89. BEAM is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $30.74 | $31.91 | $33.13 | +0.06% |
| May 30 | $30.28 | $31.93 | $33.66 | +0.12% |
| May 31 | $29.94 | $31.95 | $34.09 | +0.19% |
| Jun 1 | $29.66 | $31.97 | $34.45 | +0.25% |
| Jun 2 | $29.42 | $31.99 | $34.78 | +0.31% |
| Jun 3 | $29.21 | $32.01 | $35.08 | +0.37% |
| Jun 4 | $29.01 | $32.03 | $35.36 | +0.43% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $29.01 | $32.03 | $35.36 | +0.43% |
| Week 2 | $27.97 | $32.17 | $37.00 | +0.87% |
| Week 3 | $27.22 | $32.31 | $38.35 | +1.31% |
| Week 4 | $26.62 | $32.45 | $39.55 | +1.75% |
| Week 5 | $26.12 | $32.59 | $40.66 | +2.19% |
| Week 6 | $25.68 | $32.73 | $41.71 | +2.64% |
| Week 7 | $25.30 | $32.87 | $42.72 | +3.08% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Beam Therapeutics Inc. is a biotechnology company focused on precision genetic medicines for patients with serious diseases in the United States. Its programs include Ristoglogene autogetemcel, BEAM-302, BEAM-304, BEAM-301, the ESCAPE platform, and BEAM-103, along with collaborations with Pfizer Inc., Verve Therapeutics, and Orbital Therapeutics.
Beam Therapeutics was incorporated in 2017 and is based in Cambridge, Massachusetts.
Beam Therapeutics Inc. (BEAM) trades at $31.89. The stock sits in the Healthcare category and is listed with a current price of $31.89.
The company has a market cap of $3.28B and is ranked 1644. These numbers place BEAM among smaller biotechs with focused genetic medicine programs.
The forecast horizon suggests a neutral near-term stance in 2026 with an average price of $31.89 and a range from $21.90 to $46.70, while longer-run targets rise meaningfully: 2027 avg $36.21, 2028 avg $39.71, 2029 avg $45.88, 2030 avg $57.33, 2040 avg $117.43, and 2050 avg $283.44.
A major floor 31.3% below — a decisive break under it would weaken the trend.
The nearest floor, 17.4% below — buyers have tended to step in here.
Price is pressing into resistance (1.4% away) — a breakout level to watch.
A major ceiling 13.5% above — clearing it would confirm fresh momentum.
Key BEAM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BEAM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $29.02 | Buy | $29.70 | Buy |
| MA 10 | $28.76 | Buy | $29.35 | Buy |
| MA 20 | $29.82 | Buy | $29.36 | Buy |
| MA 50 | $28.03 | Buy | $28.75 | Buy |
| MA 100 | $28.29 | Buy | $27.87 | Buy |
| MA 200 | $25.87 | Buy | $26.46 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.29 | Neutral |
| Stoch RSI (14) | 97.04 | Sell |
| CCI (20) | 85.66 | Neutral |
| Williams %R (14) | -7.18 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -1.33 | Sell |
| Bollinger %B (20,2) | 0.77 | Neutral |
| Stochastic %K (14) | 92.82 | Sell |
| TRIX (15) | 0.10 | Buy |
| Awesome (5,34) | -0.79 | Sell |
| Ultimate (7,14,28) | 65.68 | Neutral |
| Momentum (10) | 0.31 | Buy |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 30.16 | Buy |
| ADX (14) | 14.70 | Neutral |
| ATR (14) | 1.10 | Info |
The 30-day technical picture is bullish overall. RSI14 is 60, and the stock trades with a positive tilt.
Key moving averages are SMA50 at $28.03 and SMA200 at $25.87, indicating a constructive trend relative to recent prices. Support is at $26.33 and resistance at $32.34, framing a near-term trading band.
The 30-day range runs from $24.92 to $40.81, reflecting volatility but with upside potential in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $21.90 | $31.89 | $46.70 | 0% | Neutral | |
| $27.69 | $36.21 | $50.73 | +14% | Neutral | |
| $29.21 | $39.71 | $58.27 | +25% | Bullish | |
| $32.65 | $45.88 | $69.81 | +44% | Bullish | |
| $39.63 | $57.33 | $89.95 | +80% | Bullish | |
| $45.10 | $67.05 | $108.02 | +110% | Bullish | |
| $45.47 | $69.35 | $114.41 | +117% | Bullish | |
| $47.73 | $74.57 | $125.69 | +134% | Bullish | |
| $46.42 | $74.23 | $127.60 | +133% | Bullish | |
| $45.97 | $75.17 | $131.60 | +136% | Bullish | |
| $64.73 | $117.43 | $221.77 | +268% | Bullish | |
| $129.32 | $283.44 | $596.83 | +789% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $21.90 | $31.89 | $37.85 | +0.00% |
| June 2026 | $28.44 | $33.67 | $41.01 | +5.58% |
| July 2026 | $28.17 | $33.75 | $41.85 | +0.22% |
| August 2026 | $28.17 | $34.05 | $42.83 | +0.91% |
| September 2026 | $29.47 | $35.90 | $45.66 | +5.42% |
| October 2026 | $29.87 | $36.64 | $47.08 | +2.06% |
| November 2026 | $28.84 | $35.60 | $46.14 | -2.85% |
| December 2026 | $28.78 | $35.73 | $46.70 | +0.37% |
Click any year to see its month-by-month BEAM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BEAM price prediction for 2026 points to an average of $31.89 (low $21.90, high $46.70) — a potential gain of 0% on today's $31.89. Price action looks broadly range-bound.
In 2027, BEAM is projected to trade between $27.69 and $50.73, averaging $36.21 — a potential gain of +14% from today's $31.89. That is up +14% on the projected 2026 average. A consolidation phase looks the most probable path here.
Beam Therapeutics Inc.'s 2028 outlook centres on $39.71, within a $29.21 to $58.27 range. That is up +10% on the projected 2027 average. That marks a +25% change versus current levels. Momentum favours further upside here.
By 2029, BEAM could reach as high as $69.81, with a base case around $45.88 and support toward $32.65 — roughly +44% from $31.89. Buyers look set to stay in control over this stretch.
Expect BEAM to range from $39.63 to $89.95 through 2030. The $57.33 average target implies a +80% move from current prices. That is up +25% on the projected 2029 average. Momentum favours further upside here.
The BEAM price prediction for 2031 points to an average of $67.05 (low $45.10, high $108.02) — a potential gain of +110% on today's $31.89. Buyers look set to stay in control over this stretch.
In 2032, BEAM is projected to trade between $45.47 and $114.41, averaging $69.35 — a potential gain of +117% from today's $31.89. That is up +3% on the projected 2031 average. Momentum favours further upside here.
Beam Therapeutics Inc.'s 2033 outlook centres on $74.57, within a $47.73 to $125.69 range. That is up +8% on the projected 2032 average. That marks a +134% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, BEAM could reach as high as $127.60, with a base case around $74.23 and support toward $46.42 — roughly +133% from $31.89. Momentum favours further upside here.
Expect BEAM to range from $45.97 to $131.60 through 2035. The $75.17 average target implies a +136% move from current prices. That is up +1% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The BEAM price prediction for 2040 points to an average of $117.43 (low $64.73, high $221.77) — a potential gain of +268% on today's $31.89. Momentum favours further upside here.
In 2050, BEAM is projected to trade between $129.32 and $596.83, averaging $283.44 — a potential gain of +789% from today's $31.89. That is up +141% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in BEAM today (≈ 31.357792 BEAM) could be worth
$8,888
+$7,888 (+789%) by 2050 · US Dollar
Based on the average projected BEAM price of $283.44 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BEAMwould be worth at today's price.
$1,000 invested in BEAM on May 27, 2025 (≈ 58.719904 BEAM) would be worth
$1,872.58
+$872.58 (+87.3%) today · 1.87× · US Dollar
Based on a BEAM entry price of $17.03 vs. today's $31.89.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $27.11 | $1,176.32 | +17.6% |
| 1 month ago | $29.17 | $1,093.43 | +9.3% |
| 3 months ago | $28.92 | $1,102.7 | +10.3% |
| 6 months ago | $25.33 | $1,258.98 | +25.9% |
| 1 year ago | $17.03 | $1,872.58 | +87.3% |
| All time (5.0y) ago | $77.74 | $410.21 | -59.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BEAM forecast.
Our base-case forecast reaches $64.00 around 2031.
Implied market cap at $64.00: $6.58B
From 2026 through 2029, the forecast shows prices moving higher on average: 2026 (avg $31.89, min $21.90, max $46.70) with neutral sentiment, then 2027 (avg $36.21) and 2028 (avg $39.71) progressing to 2029 (avg $45.88) with bullish momentum and rising ROIs (0% in 2026, 13.6% in 2027, 24.5% in 2028, 43.9% in 2029).
In 2030 the forecast projects an average of $57.33 with a bullish sentiment and an ROI of 79.8%, followed by 2031 (avg $67.05, ROI 110.3%) and 2032 (avg $69.35, ROI 117.5%). The trajectory continues with 2033 (avg $74.57, ROI 133.8%), 2034 (avg $74.23, ROI 132.8%), and 2035 (avg $75.17, ROI 135.7%), all Bullish.
Accepting higher levels in the long term, 2040 shows an average of $117.43 with an ROI of 268.2%, and 2050 hosts a forecast average of $283.44 with an ROI of 788.8% and a min of $129.32 and a max of $596.83. These are estimates and are not guarantees, subject to market conditions and the development of the company’s programs.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $57.33 with a min of $39.63 and a max of $89.95, and an ROI of 79.8%, with bullish sentiment.
Forecasts show bullish sentiment in later years and rising average prices through 2050, with 2026 avg $31.89 (neutral) and 2050 avg $283.44 with ROI up to 788.8%. These are estimates and not guarantees.
Yes. The forecast shows a max of $108.02 in 2031 and $114.41 in 2032, indicating a possibility of surpassing $100 in those years.
The forecast for 2050 is an average of $283.44 with a min of $129.32 and a max of $596.83, and an ROI of 788.8% with bullish sentiment.
Current price is $31.89 and market cap is $3.28B.
Beam Therapeutics Inc. Community Discussion
0Share your Beam Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.